These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. ORL1 receptor ligands: structure-activity relationships of 8-cycloalkyl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-ones. Röver S; Wichmann J; Jenck F; Adam G; Cesura AM Bioorg Med Chem Lett; 2000 Apr; 10(8):831-4. PubMed ID: 10782696 [TBL] [Abstract][Full Text] [Related]
23. 123I-MSP and F[11C]MSP: new selective 5-HT2A receptor radiopharmaceuticals for in vivo studies of neuronal 5-HT2 serotonin receptors. Synthesis, in vitro binding study with unlabelled analogues and preliminary in vivo evaluation in mice. Samnick S; Remy N; Ametamey S; Bader JB; Brandau W; Kirsch CM Life Sci; 1998; 63(22):2001-13. PubMed ID: 9839544 [TBL] [Abstract][Full Text] [Related]
24. Orphanin FQ/nociceptin but not Ro 65-6570 inhibits the expression of cocaine-induced conditioned place preference. Kotlińska J; Wichmann J; Legowska A; Rolka K; Silberring J Behav Pharmacol; 2002 May; 13(3):229-35. PubMed ID: 12122313 [TBL] [Abstract][Full Text] [Related]
25. Is the nociceptin (NOP) receptor involved in attenuation of the expression of sensitization to morphine-induced hyperlocomotion in mice? Kotlinska J; Rafalski P; Talarek S; Dylag T; Rolka K; Wichmann J; Silberring J Behav Pharmacol; 2005 Mar; 16(2):101-6. PubMed ID: 15767845 [TBL] [Abstract][Full Text] [Related]
26. Ligand-regulated internalization of the opioid receptor-like 1: a confocal study. Corbani M; Gonindard C; Meunier JC Endocrinology; 2004 Jun; 145(6):2876-85. PubMed ID: 15016723 [TBL] [Abstract][Full Text] [Related]
27. Evidence in locomotion test for the functional heterogeneity of ORL-1 receptors. Kuzmin A; Sandin J; Terenius L; Ogren SO Br J Pharmacol; 2004 Jan; 141(1):132-40. PubMed ID: 14662736 [TBL] [Abstract][Full Text] [Related]
28. Roles of μ-opioid receptors and nociceptin/orphanin FQ peptide receptors in buprenorphine-induced physiological responses in primates. Cremeans CM; Gruley E; Kyle DJ; Ko MC J Pharmacol Exp Ther; 2012 Oct; 343(1):72-81. PubMed ID: 22743574 [TBL] [Abstract][Full Text] [Related]
29. A combined pharmacological and genetic approach to investigate the role of orphanin FQ in learning and memory. Higgins GA; Kew JN; Richards JG; Takeshima H; Jenck F; Adam G; Wichmann J; Kemp JA; Grottick AJ Eur J Neurosci; 2002 Mar; 15(5):911-22. PubMed ID: 11906533 [TBL] [Abstract][Full Text] [Related]
30. Effects of nociceptin/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice: comparison to morphine. Reiss D; Wichmann J; Tekeshima H; Kieffer BL; Ouagazzal AM Eur J Pharmacol; 2008 Jan; 579(1-3):141-8. PubMed ID: 18031727 [TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and evaluation of [(3)H]PF-7191, a highly specific nociceptin opioid peptide (NOP) receptor radiotracer for in vivo receptor occupancy (RO) studies. Zhang L; Drummond E; Brodney MA; Cianfrogna J; Drozda SE; Grimwood S; Vanase-Frawley MA; Villalobos A Bioorg Med Chem Lett; 2014 Nov; 24(22):5219-23. PubMed ID: 25442316 [TBL] [Abstract][Full Text] [Related]
32. In vivo quantification of calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C]MK-4232. Hostetler ED; Joshi AD; Sanabria-Bohórquez S; Fan H; Zeng Z; Purcell M; Gantert L; Riffel K; Williams M; O'Malley S; Miller P; Selnick HG; Gallicchio SN; Bell IM; Salvatore CA; Kane SA; Li CC; Hargreaves RJ; de Groot T; Bormans G; Van Hecken A; Derdelinckx I; de Hoon J; Reynders T; Declercq R; De Lepeleire I; Kennedy WP; Blanchard R; Marcantonio EE; Sur C; Cook JJ; Van Laere K; Evelhoch JL J Pharmacol Exp Ther; 2013 Nov; 347(2):478-86. PubMed ID: 23975906 [TBL] [Abstract][Full Text] [Related]
34. The hypnotic, electroencephalographic, and antinociceptive properties of nonpeptide ORL1 receptor agonists after intravenous injection in rodents. Byford AJ; Anderson A; Jones PS; Palin R; Houghton AK Anesth Analg; 2007 Jan; 104(1):174-9. PubMed ID: 17179266 [TBL] [Abstract][Full Text] [Related]
35. Functional heterogeneity of nociceptin/orphanin FQ receptors revealed by (+)-5a Compound and Ro 64-6198 in rat periaqueductal grey slices. Liao YY; Teng SF; Lin LC; Kolczewski S; Prinssen EP; Lee LJ; Ho IK; Chiou LC Int J Neuropsychopharmacol; 2011 Aug; 14(7):977-89. PubMed ID: 21029514 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and in vivo evaluation of [11C]SA6298 as a PET sigma1 receptor ligand. Kawamura K; Ishiwata K; Tajima H; Ishii S; Shimada Y; Matsuno K; Homma Y; Senda M Nucl Med Biol; 1999 Nov; 26(8):915-22. PubMed ID: 10708305 [TBL] [Abstract][Full Text] [Related]
37. The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications. Zaveri NT Curr Top Med Chem; 2011; 11(9):1151-6. PubMed ID: 21050175 [TBL] [Abstract][Full Text] [Related]
38. Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide. Shimohigashi Y; Hatano R; Fujita T; Nakashima R; Nose T; Sujaku T; Saigo A; Shinjo K; Nagahisa A J Biol Chem; 1996 Sep; 271(39):23642-5. PubMed ID: 8798582 [TBL] [Abstract][Full Text] [Related]
39. Nociceptin/orphanin FQ: role in nociceptive information processing. Yamamoto T; Nozaki-Taguchi N; Sakashita Y; Kimura S Prog Neurobiol; 1999 Apr; 57(5):527-35. PubMed ID: 10215100 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of 5-(11)C-methyl-A-85380 as an imaging agent for PET investigations of brain nicotinic acetylcholine receptors. Iida Y; Ogawa M; Ueda M; Tominaga A; Kawashima H; Magata Y; Nishiyama S; Tsukada H; Mukai T; Saji H J Nucl Med; 2004 May; 45(5):878-84. PubMed ID: 15136639 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]